COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. South Carolina patients with a documented clinical need may be eligible for compounded tirzepatide.
South Carolina’s healthcare is centered in Charleston, Columbia, and Greenville, with rural Lowcountry and Pee Dee regions having fewer local options. Compounding Finder helps South Carolina residents compare licensed pharmacies.
Yes. The South Carolina Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.